Related Experiment Video
Updated: Oct 25, 2025

Intravitreal Injections in the Ovine Eye
Published on: July 5, 2022
Statins in Neuro-ophthalmology
Alvin Tan1, Clare Fraser1, Pauline Khoo1
1Discipline of Ophthalmology, Faculty of Health and Medicine, The University of Sydney, Save Sight Institute, Sydney, New South Wales, Australia.
Abstract:
Statins are effective and well-tolerated hypolipidaemic agents which have been increasingly studied for their pleiotropic immunomodulatory and anti-inflammatory effects. Statins have potential therapeutic benefit in a range of neuro-ophthalmological conditions but may also induce or exacerbate certain neurological disorders. This literature review examines evidence from clinical and in vitro studies assessing the effects of statins in myasthenia gravis, myopathy, multiple sclerosis, neuromyelitis optica, idiopathic intracranial hypertension (pseudotumour cerebri), migraine, giant cell arteritis, Bell's palsy, ocular ischaemia, stroke, Alzheimer's disease and Parkinson's disease.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...

